Applications close 12 November, 17:00 AEDT

For the first time, Cure Brain Cancer
Foundation and the National Breast Cancer Foundation have come together to
jointly fund high impact translational research that spans both primary bran
cancer and breast cancers to improve survival for people diagnosed with these
diseases.

Leading researchers from both cancers will
investigate the connections between primary brain cancer and breast cancer.
This will facilitate new, innovative approaches to tackling the diseases,
potentially transforming the clinical management of both cancers by delivering
meaningful patient outcomes significantly faster.

The jointly funded $1 million grant ($500,000 from
each foundation) will be awarded to new, high-impact research, which spans both
primary brain cancer and breast cancer, and seeks to improve survival for
people living with both diseases. In addition, projects will be judged on
excellence in project design and infrastructure, and must be complemented by an
outstanding team of scientists, while demonstrating alignment to the missions
of both Cure Brain Cancer Foundation and the National Breast Cancer Foundation.

FUNDING DETAILS

The
total funding available is AUD$1 million over 3 to 5 years which will fund one
or two research projects. The total requested budget must not exceed AUD$1
million. All applications will be subject to a thorough budget review as part
of the peer review process.

Deadline passed 19 March, 17:00 AEDT

This grant will provide support to key research groups that currently develop primary brain cancer model systems and provide these as a resource to other research groups. Model systems are a valuable resource to quality medical research and it is vital that Australian researchers have access to this critical technology to accelerate the number and quality of potential brain cancer agents to clinical trials.

Successful applications will demonstrate collaboration and mentorship to other groups in Australia and will be prepared to continue to collaborate and build capacity in Australian brain cancer research.

FUNDING DETAILS

This Infrastructure grant-in-aid will provide up to $400,000. That is, up to $100,000 per year for four years.

ELIGIBILITY

We encourage applications from researchers that provide, and aim to continuously improve models for basic science and translational research of brain cancer and the testing of potential treatments.

Applicants must demonstrate that they have previously provided support and resources to researchers at multiple institutions. Applicants must be prepared to continue to collaborate to increase the scale and quality of Australian brain cancer research through technology and mentorship.

Deadline passed 20 April 2018, 17.00 AEST

Default preview for : Iframe

Innovation Grants aim to fund new research projects that deviate from existing paradigms and current lines of investigation. These grants allow investigators to follow leading observations and exploration of novel ideas in brain cancer research. They support investigators to produce proof-of-concept data for their higher-risk projects and establish feasibility for future research and grant applications.

Funding Details

Innovation Grants-in-aid will offer up to $200,000 over two years.

Eligibility

Principal Investigators must:

Undertake research at an Australian research institution.

Use any awarded funds to work on novel* research applicable to primary brain cancer.

Cure Brain Cancer Foundation's Immunotherapy Trial Grants-in-aid will provide funding for a clinical study that investigates an immunotherapeutic agent and has the objective of increasing overall survival for patients with primary brain cancer. This clinical trial can focus on any age group.

Funding Details

The Immunotherapy Trial Grant-in-aid will offer up to $500,000 over three years.

Undertake research at an Australian research institution.

Have at least one trial site in New South Wales.

Investigate an immunotherapeutic agent.

2017 Early Career Fellowship

Deadline passed 18 August 2017, 17.00 AEST

Default preview for : Iframe

Cure Brain Cancer’s Early Career Fellowships aim to support bright young researchers to develop their career in brain cancer research. Cure Brain Cancer believes that it is important to build capacity in innovative brain cancer research and development to achieve our mission of improving survival for people living with brain cancer. It is expected that Fellows undertake a significant piece of publishable work during their tenure that will lead to a more permanent position within the brain cancer research field.

Funding Details

The Cure Brain Cancer Early Career Fellowship will offer grants-in-aid of up to $115,000 per year for three years. Including up to $100,000 salary (depending on experience and academic level), and $15,000 for research costs, including up to $5,000 for travel and conferences per year.

If the applicant is successful with an NHMRC or Cancer Australia or other Fellowship then this must be disclosed to CBCF and the CBCF contribution will be revised down to an appropriate top-up level depending on individual circumstances.

Eligibility

Applicants must:

Be eligible to work in Australia for the duration of the award.

Undertake research at an Australian research institution.

Have been awarded their PhD within the last six years prior to 30 June in the year of application (i.e. 2017). The start date should be taken from the date the PhD thesis was passed (not the date of degree conferral). Consideration will also be given to final year PhD students, whose PhD will be submitted by December 2017 and approved before Fellowship begins in early 2018.

Have a proven track record of research but not held an established academic appointment.